Cytoplasmic CD133 Expression is a Reliable Prognostic Indicator of Tumor Regression After Neoadjuvant Concurrent Chemoradiotherapy in Patients with Rectal Cancer

✍ Scribed by Jao, Shu-Wen; Chen, Su-Feng; Lin, Yaoh-Shiang; Chang, Yun-Ching; Lee, Tsai-Yu; Wu, Chang-Chieh; Jin, Jong-Shiaw; Nieh, Shin

• Book ID: 120283973
• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 812 KB
• Volume: 19
• Category: Article
• ISSN: 1068-9265
• DOI: 10.1245/s10434-012-2394-3